ZA200200742B - Multi-dose erythropoietin formulations. - Google Patents

Multi-dose erythropoietin formulations.

Info

Publication number
ZA200200742B
ZA200200742B ZA200200742A ZA200200742A ZA200200742B ZA 200200742 B ZA200200742 B ZA 200200742B ZA 200200742 A ZA200200742 A ZA 200200742A ZA 200200742 A ZA200200742 A ZA 200200742A ZA 200200742 B ZA200200742 B ZA 200200742B
Authority
ZA
South Africa
Prior art keywords
formulations
dose erythropoietin
erythropoietin formulations
dose
phenoxyethanol
Prior art date
Application number
ZA200200742A
Other languages
English (en)
Inventor
Atef Gayed
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of ZA200200742B publication Critical patent/ZA200200742B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA200200742A 1999-07-22 2002-01-28 Multi-dose erythropoietin formulations. ZA200200742B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19821699P 1999-07-22 1999-07-22

Publications (1)

Publication Number Publication Date
ZA200200742B true ZA200200742B (en) 2003-06-25

Family

ID=22732468

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200742A ZA200200742B (en) 1999-07-22 2002-01-28 Multi-dose erythropoietin formulations.

Country Status (25)

Country Link
US (1) US7432360B2 (hu)
EP (1) EP1200115B9 (hu)
JP (1) JP2003517462A (hu)
KR (1) KR100693263B1 (hu)
CN (2) CN1371284A (hu)
AT (1) ATE304863T1 (hu)
AU (1) AU777397B2 (hu)
BR (1) BR0012667A (hu)
CA (1) CA2378945C (hu)
CZ (1) CZ302750B6 (hu)
DE (1) DE60022759T2 (hu)
DK (1) DK1200115T3 (hu)
EA (1) EA006220B1 (hu)
EE (1) EE200200037A (hu)
ES (1) ES2248110T3 (hu)
HK (1) HK1050318A1 (hu)
HR (1) HRP20020159B1 (hu)
HU (1) HUP0202246A3 (hu)
IL (2) IL147755A0 (hu)
NO (1) NO20020303L (hu)
NZ (1) NZ516735A (hu)
PL (1) PL202945B1 (hu)
RS (1) RS50355B (hu)
WO (1) WO2001007075A2 (hu)
ZA (1) ZA200200742B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1371287A (zh) 1999-07-22 2002-09-25 阿温蒂斯药物公司 防腐的药物制剂
JP3967594B2 (ja) 2000-05-15 2007-08-29 エフ．ホフマン−ラ ロシュ アーゲー 新しい薬剤組成物
UA89630C2 (ru) * 2004-03-26 2010-02-25 Янссен Фармацевтика Н.В. Схема комбинированного дозирования для эритропоэтина
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
US8877234B2 (en) * 2005-02-03 2014-11-04 Clariant Finance (Bvi) Limited Preservatives
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
KR101805087B1 (ko) 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
CA3001429C (en) * 2015-10-22 2023-07-11 Iltoo Pharma Pharmaceutical compositions of il-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
JP2532025B2 (ja) * 1993-07-23 1996-09-11 株式会社林原生物化学研究所 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
US5968899A (en) * 1994-06-03 1999-10-19 Tsumura & Co. Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
JP2000504319A (ja) * 1996-01-19 2000-04-11 イーライ・リリー・アンド・カンパニー 肥満症タンパク質製剤
CN1233963A (zh) * 1996-09-13 1999-11-03 有限会社最先端医学研究所 神经营养因子的眼科用组合物、视神经机能障碍治疗药和视神经机能障碍治疗方法
JPH1112193A (ja) * 1997-06-19 1999-01-19 Sankyo Co Ltd ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine

Also Published As

Publication number Publication date
EP1200115B9 (en) 2006-01-18
HUP0202246A3 (en) 2010-01-28
IL147755A0 (en) 2002-08-14
BR0012667A (pt) 2002-07-02
EA200200073A1 (ru) 2002-08-29
ATE304863T1 (de) 2005-10-15
KR20020011143A (ko) 2002-02-07
HUP0202246A2 (en) 2002-10-28
US7432360B2 (en) 2008-10-07
EP1200115B1 (en) 2005-09-21
YU4702A (sh) 2005-06-10
US20050267033A1 (en) 2005-12-01
RS50355B (sr) 2009-11-10
WO2001007075A2 (en) 2001-02-01
JP2003517462A (ja) 2003-05-27
CN101091792A (zh) 2007-12-26
HK1050318A1 (zh) 2003-06-20
AU7137400A (en) 2001-02-13
CZ2002264A3 (cs) 2002-06-12
NO20020303L (no) 2002-03-21
HRP20020159B1 (en) 2007-08-31
EA006220B1 (ru) 2005-10-27
AU777397B2 (en) 2004-10-14
PL202945B1 (pl) 2009-08-31
KR100693263B1 (ko) 2007-03-13
CZ302750B6 (cs) 2011-10-19
NO20020303D0 (no) 2002-01-21
CA2378945C (en) 2010-02-23
IL147755A (en) 2009-11-18
CA2378945A1 (en) 2001-02-01
DK1200115T3 (da) 2006-01-16
ES2248110T3 (es) 2006-03-16
PL353569A1 (en) 2003-12-01
HRP20020159A2 (en) 2003-06-30
CN1371284A (zh) 2002-09-25
DE60022759T2 (de) 2006-06-22
WO2001007075A3 (en) 2001-10-04
DE60022759D1 (de) 2006-02-02
EP1200115A2 (en) 2002-05-02
EE200200037A (et) 2003-04-15
NZ516735A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
DE69730202D1 (de) Azidfreie, gaserzeugende zusammensetzungen
ZA99780B (en) Styling shampoo compositions.
AU2002215935A1 (en) Novel use of short-chained carboxylic acids
FR2770110B1 (fr) Boitier, du type boitier de maquillage
BG101540A (en) Interferon conjugates
ID23374A (id) Halogenopirimidin
ZA200005478B (en) Shampoo compositions.
AU3950099A (en) Hair styling compositions
HK1046004A1 (en) Recombinant gelatins
ZA979284B (en) Styling shampoo compositions with improved styling polymer deposition.
EP1060738A3 (en) Self-tanning composition comprising carmine
IT1302347B1 (it) Procedimento per la produzione diretta di perossido di idrogeno.
EP1083903A4 (en) INDENOPYRROLOCARBAZOLES BRIDGES
ZA995770B (en) Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibres, dyeing compositions, and methods of dyeing.
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
NZ523367A (en) Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
IL147755A0 (en) Multi-dose erythropoietin formulations
DE69616074D1 (de) Ara-c derivate
EP0983243A4 (en) NOVEL QUINOLINE- AND NAPHTHALENECARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING CALPAIN
NO990498D0 (no) 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon
ATE241599T1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate
AP9901529A0 (en) Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them.
WO1999061598A3 (en) Lentiviral vector compositions and methods of use
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
HK1049485A1 (en) DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses.